Leaman John Harold 4
4 · IMPEL NEUROPHARMA INC · Filed Jul 26, 2021
Insider Transaction Report
Form 4
Leaman John Harold
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2021-07-20+50,000→ 50,000 totalExercise: $12.16Exp: 2031-07-19→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The option vests as to 2.0833% of the total shares on August 22, 2021 and then 2.0833% of the total shares vests monthly thereafter, with 100% of the total shares vested and exercisable on July 22, 2025, subject to the reporting person's provision of service to the issuer on each vesting date.